Paper22504652
Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection.
Biswas S and 6 others. J Immunol, 2012. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection. Papers, record 22504652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22504652
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenoviruses, Human | Major topic |
| Antigens, Protozoan | Major topic |
| Malaria Vaccines | Major topic |
| Malaria, Falciparum | Major topic |
| Membrane Proteins | Major topic |
| Plasmodium falciparum | Major topic |
| Protozoan Proteins | Major topic |
| Animals | |
| Antibodies, Protozoan | |
| Antibodies, Viral | |
| Female | |
| Genetic Vectors | |
| Humans | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Knockout | |
| Mice, Nude | |
| Molecular Sequence Data | |
| Plasmodium chabaudi | |
| Vaccines, Subunit | |
| Vaccines, Synthetic | |
| Vaccinia virus |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| G0700735(82115) | Medical Research Council | United Kingdom | PubMed | |
| G1000527 | Medical Research Council | United Kingdom | PubMed | |
| U117532067 | Medical Research Council | United Kingdom | PubMed | |
| 095540 | Wellcome Trust | United Kingdom | PubMed | |
| 090532 | Wellcome Trust | United Kingdom | PubMed | |
| MC_U117532067 | Medical Research Council | United Kingdom | PubMed | |
| G1000527(95710) | Medical Research Council | United Kingdom | PubMed | |
| G0700735 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12097400 | Identification of T cell epitopes on the 33-kDa fragment of Plasmodium yoelii merozoite surface protein 1 and their antibody-independent protective role in immunity to blood stage malaria. | J Immunol | 2002 | https://conductscience.org/library/papers/12097400 | PubMed |
| 2 | 21862998 | Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors. | Mol Ther | 2011 | https://conductscience.org/library/papers/21862998 | PubMed |
| 3 | 19093004 | Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02. | PLoS One | 2008 | https://conductscience.org/library/papers/19093004 | PubMed |
| 4 | 19050274 | Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. | J Immunol | 2008 | https://conductscience.org/library/papers/19050274 | PubMed |
| 5 | 10861076 | CD4+ T cells acting independently of antibody contribute to protective immunity to Plasmodium chabaudi infection after apical membrane antigen 1 immunization. | J Immunol | 2000 | https://conductscience.org/library/papers/10861076 | PubMed |
| 6 | 9317139 | Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells. | J Immunol | 1997 | https://conductscience.org/library/papers/9317139 | PubMed |
| 7 | 9607037 | Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. | Vaccine | 1998 | https://conductscience.org/library/papers/9607037 | PubMed |
| 8 | 2523712 | TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. | Annu Rev Immunol | 1989 | https://conductscience.org/library/papers/2523712 | PubMed |
| 9 | 20507694 | Blood-stage malaria vaccines - recent progress and future challenges. | Ann Trop Med Parasitol | 2010 | https://conductscience.org/library/papers/20507694 | PubMed |
| 10 | 20713623 | New candidate vaccines against blood-stage Plasmodium falciparum malaria: prime-boost immunization regimens incorporating human and simian adenoviral vectors and poxviral vectors expressing an optimized antigen based on merozoite surface protein 1. | Infect Immun | 2010 | https://conductscience.org/library/papers/20713623 | PubMed |
| 11 | 21893544 | Vaccines against malaria. | Philos Trans R Soc Lond B Biol Sci | 2011 | https://conductscience.org/library/papers/21893544 | PubMed |
| 12 | 20628205 | Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in mice. | J Clin Invest | 2010 | https://conductscience.org/library/papers/20628205 | PubMed |
| 13 | 15972624 | Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. 1986. | J Immunol | 2005 | https://conductscience.org/library/papers/15972624 | PubMed |
| 14 | 19966816 | Viruses as vaccine vectors for infectious diseases and cancer. | Nat Rev Microbiol | 2010 | https://conductscience.org/library/papers/19966816 | PubMed |
| 15 | 19858306 | Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses. | Infect Immun | 2010 | https://conductscience.org/library/papers/19858306 | PubMed |
| 16 | 22363582 | Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors. | PLoS One | 2012 | https://conductscience.org/library/papers/22363582 | PubMed |
| 17 | 21265010 | SPICE: exploration and analysis of post-cytometric complex multivariate datasets. | Cytometry A | 2011 | https://conductscience.org/library/papers/21265010 | PubMed |
| 18 | 20138874 | Regulation of immunity to Plasmodium: implications from mouse models for blood stage malaria vaccine design. | Exp Parasitol | 2010 | https://conductscience.org/library/papers/20138874 | PubMed |
| 19 | 12379684 | Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii. | Infect Immun | 2002 | https://conductscience.org/library/papers/12379684 | PubMed |
| 20 | 19154991 | Recombinant viral vaccines expressing merozoite surface protein-1 induce antibody- and T cell-mediated multistage protection against malaria. | Cell Host Microbe | 2009 | https://conductscience.org/library/papers/19154991 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36140395 | Protective Immunity Induced by Immunization with Baculovirus, Virus-like Particle, and Vaccinia Virus Expressing the AMA1 of Plasmodium berghei. | Biomedicines | 2022 | https://conductscience.org/library/papers/36140395 | PubMed |
| 32228600 | Immunogenicity analysis of conserved fragments in Plasmodium ovale species merozoite surface protein 4. | Malar J | 2020 | https://conductscience.org/library/papers/32228600 | PubMed |
| 30846985 | Infection-Induced Resistance to Experimental Cerebral Malaria Is Dependent Upon Secreted Antibody-Mediated Inhibition of Pathogenic CD8+ T Cell Responses. | Front Immunol | 2019 | https://conductscience.org/library/papers/30846985 | PubMed |
| 30770839 | Reverse immunodynamics: a new method for identifying targets of protective immunity. | Sci Rep | 2019 | https://conductscience.org/library/papers/30770839 | PubMed |
| 26511884 | Recombinant modified vaccinia virus Ankara-based malaria vaccines. | Expert Rev Vaccines | 2016 | https://conductscience.org/library/papers/26511884 | PubMed |
| 25590760 | A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys. | Cell Host Microbe | 2015 | https://conductscience.org/library/papers/25590760 | PubMed |
| 25120545 | Strategies for designing and monitoring malaria vaccines targeting diverse antigens. | Front Immunol | 2014 | https://conductscience.org/library/papers/25120545 | PubMed |
| 24303947 | Analysis of human B-cell responses following ChAd63-MVA MSP1 and AMA1 immunization and controlled malaria infection. | Immunology | 2014 | https://conductscience.org/library/papers/24303947 | PubMed |
| 23836827 | Immunization with apical membrane antigen 1 confers sterile infection-blocking immunity against Plasmodium sporozoite challenge in a rodent model. | Infect Immun | 2013 | https://conductscience.org/library/papers/23836827 | PubMed |
| 23778312 | Challenges of assessing the clinical efficacy of asexual blood-stage Plasmodium falciparum malaria vaccines. | Hum Vaccin Immunother | 2013 | https://conductscience.org/library/papers/23778312 | PubMed |
| 23746455 | Utilizing poxviral vectored vaccines for antibody induction-progress and prospects. | Vaccine | 2013 | https://conductscience.org/library/papers/23746455 | PubMed |
| 23609325 | The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment. | Sci Rep | 2013 | https://conductscience.org/library/papers/23609325 | PubMed |
| 23293353 | Assessment of immune interference, antagonism, and diversion following human immunization with biallelic blood-stage malaria viral-vectored vaccines and controlled malaria infection. | J Immunol | 2013 | https://conductscience.org/library/papers/23293353 | PubMed |
| 23089736 | ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans. | Mol Ther | 2012 | https://conductscience.org/library/papers/23089736 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| PLAT | 5327 | PubTator's text mining | https://conductscience.org/library/genes/5327 | NCBI Gene |
| TLR9 | 54106 | PubTator's text mining | https://conductscience.org/library/genes/54106 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GENBANK | JF690775 |
Source GENBANK
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22504652
GET https://conductscience.org/api/papers/v1/22504652/references?page=2